Malignant Eye Neoplasm — Trials

Malignant Eye Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

446 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 83
Recruiting: 44
Ph III recruiting: 10
Growth YoY: —
Industry share: 30%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02933333	G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor	unknown	Phase 4	405	Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Oct 17, 2018	clinicaltrials
NCT02379000	TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy	unknown	Phase 4	50	Charite University, Berlin, GermanyOTHER	1	Feb 8, 2017